Daily Study

A lower session: SPY −0.37%, QQQ −0.58%

Three screens filtered 1,894 US stocks down to 12 names on this page: the top and the bottom of each ordering. 10 of 12 closed lower and 2 higher; small caps (IWM) moved −0.68%.

SPY−0.37%
S&P 500 ETF749.93
QQQ−0.58%
Nasdaq 100 ETF674.82
IWM−0.68%
Russell 2000 ETF280.55
DIA−0.29%
Dow 30 ETF521.80
names screened
1,894
studied in depth
146
on this page
12
screens
3

A record of what moved, not a recommendation.Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRLMethodologyDisclaimer

Each screen starts from a broad filter of US stocks; the candidates are then ordered by a combined fundamentals-and-trend read. The page shows the names at the top and at the bottom of that order, so you see both ends of the same filter, not a pick list. Open any case study for the session, the three-month trend and the latest SEC financials. IEX volume is only the share traded on IEX, so it is compared with its own 20-day average.

Learn more: Top and Bottom of the Screen: An Ordering, Not a Verdict · Where the Numbers Come From: IEX Prices and SEC Filings · Reading the Cash Flow Statement · Return on Equity and Leverage

499matched the screen
60studied in depth
4on this page

Top of the screen

CRCT

Cricut Inc

8.66−1.4%
TechnologyComputer Hardware
3 months+46.4%
52-week range52w low83%high
RSI (14)72
Session
above VWAP 8.600.85× avg vol
Moving averages
above 50dabove 200d
View CRCT chart on TradingView Affiliate
Case study: why CRCT is on this page

Top of this screen: profitable last fiscal year; revenue -0.5% YoY; above its 200-day average; +46.4% over 3 months.

Close 8.66: −1.4% vs previous closeSession (open→close): −0.6%

Session: day range 8.46–8.75, VWAP 8.60 (above VWAP), IEX volume 0.85× its 20-day average. Trend: +46.4% over three months, 83% of the way up its 52-week range, RSI(14) 72, above its 50-day and above its 200-day average.

Intraday chart of CRCT on 2026-11-10
Session (intraday)
Three-month daily chart of CRCT
Three months (daily)
Revenue (latest FY)
$708.8M
Net income (latest FY)
$76.7M
Cash
$174.6M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Cricut Inc filings on SEC EDGAR

WOOF

Petco Health and Wellness Co Inc

2.92−5.8%
Consumer CyclicalSpecialty Retail
3 months+1.6%
52-week range52w low47%high
RSI (14)62
Session
below VWAP 2.950.78× avg vol
Moving averages
above 50dabove 200d
View WOOF chart on TradingView Affiliate
Case study: why WOOF is on this page

Top of this screen: profitable last fiscal year; revenue -2.5% YoY; above its 200-day average.

Close 2.92: −5.8% vs previous closeSession (open→close): −5.2%

Session: day range 2.92–3.08, VWAP 2.95 (below VWAP), IEX volume 0.78× its 20-day average. Trend: +1.6% over three months, 47% of the way up its 52-week range, RSI(14) 62, above its 50-day and above its 200-day average.

Intraday chart of WOOF on 2026-11-10
Session (intraday)
Three-month daily chart of WOOF
Three months (daily)
Revenue (latest FY)
$5.96B
Net income (latest FY)
$9.1M
Cash
$293.5M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Petco Health and Wellness Co Inc filings on SEC EDGAR

Bottom of the screen

ARTV

Artiva Biotherapeutics Inc

4.06−3.9%
HealthcareBiotechnology
3 months−64.0%
52-week range52w low9%high
RSI (14)22
Session
below VWAP 4.091.08× avg vol
Moving averages
below 50dbelow 200d
View ARTV chart on TradingView Affiliate
Case study: why ARTV is on this page

Bottom of this screen: a net loss last fiscal year; revenue -100.0% YoY; below its 200-day average; near its 52-week low; -64.0% over 3 months.

Close 4.06: −3.9% vs previous closeSession (open→close): −2.4%

Session: day range 4.04–4.21, VWAP 4.09 (below VWAP), IEX volume 1.08× its 20-day average. Trend: −64.0% over three months, 9% of the way up its 52-week range, RSI(14) 22, below its 50-day and below its 200-day average.

Intraday chart of ARTV on 2026-11-10
Session (intraday)
Three-month daily chart of ARTV
Three months (daily)
Revenue (latest FY)
$0
Net income (latest FY)
−$83.9M
Cash
$61.2M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Artiva Biotherapeutics Inc filings on SEC EDGAR

PROK

ProKidney Corp

1.12−3.4%
HealthcareBiotechnology
3 months−20.3%
52-week range52w low12%high
RSI (14)36
Session
above VWAP 1.100.89× avg vol
Moving averages
below 50dbelow 200d
View PROK chart on TradingView Affiliate
Case study: why PROK is on this page

Bottom of this screen: a net loss last fiscal year; revenue +1075.0% YoY; below its 200-day average; -20.3% over 3 months.

Close 1.12: −3.4% vs previous closeSession (open→close): −0.4%

Session: day range 1.07–1.15, VWAP 1.10 (above VWAP), IEX volume 0.89× its 20-day average. Trend: −20.3% over three months, 12% of the way up its 52-week range, RSI(14) 36, below its 50-day and below its 200-day average.

Intraday chart of PROK on 2026-11-10
Session (intraday)
Three-month daily chart of PROK
Three months (daily)
Revenue (latest FY)
$893.0K
Net income (latest FY)
−$69.0M
Cash
$74.9M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: ProKidney Corp filings on SEC EDGAR

1,369matched the screen
60studied in depth
4on this page

Top of the screen

FULT

Fulton Financial Corp

23.99−0.6%
FinancialBanks - Regional
3 months−2.2%
52-week range52w low85%high
RSI (14)58
Session
at VWAP 23.980.45× avg vol
Moving averages
above 50dabove 200d
View FULT chart on TradingView Affiliate
Case study: why FULT is on this page

Top of this screen: profitable last fiscal year; revenue -6.5% YoY; above its 200-day average.

Close 23.99: −0.6% vs previous closeSession (open→close): −0.9%

Session: day range 23.80–24.27, VWAP 23.98 (at VWAP), IEX volume 0.45× its 20-day average. Trend: −2.2% over three months, 85% of the way up its 52-week range, RSI(14) 58, above its 50-day and above its 200-day average.

Intraday chart of FULT on 2026-11-10
Session (intraday)
Three-month daily chart of FULT
Three months (daily)
Revenue (latest FY)
$276.8M
Net income (latest FY)
$391.6M
Cash
$1.11B

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Fulton Financial Corp filings on SEC EDGAR

DXC

DXC Technology Co

15.32+1.0%
TechnologyInformation Technology Services
3 months+36.7%
52-week range52w low88%high
RSI (14)60
Session
at VWAP 15.290.43× avg vol
Moving averages
above 50dabove 200d
View DXC chart on TradingView Affiliate
Case study: why DXC is on this page

Top of this screen: profitable last fiscal year; revenue -1.8% YoY; above its 200-day average; +36.7% over 3 months.

Close 15.32: +1.0% vs previous closeSession (open→close): +1.7%

Session: day range 14.91–15.53, VWAP 15.29 (at VWAP), IEX volume 0.43× its 20-day average. Trend: +36.7% over three months, 88% of the way up its 52-week range, RSI(14) 60, above its 50-day and above its 200-day average.

Intraday chart of DXC on 2026-11-10
Session (intraday)
Three-month daily chart of DXC
Three months (daily)
Revenue (latest FY)
$12.64B
Net income (latest FY)
$18.0M
Cash
$1.60B

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: DXC Technology Co filings on SEC EDGAR

Bottom of the screen

IONS

Ionis Pharmaceuticals Inc

28.15−9.2%
HealthcareBiotechnology
3 months−49.6%
52-week range52w low1%high
RSI (14)18
Session
below VWAP 28.612.75× avg vol
Moving averages
below 50dbelow 200d
View IONS chart on TradingView Affiliate
Case study: why IONS is on this page

Bottom of this screen: a net loss last fiscal year; revenue +33.8% YoY; below its 200-day average; near its 52-week low; -49.6% over 3 months.

Close 28.15: −9.2% vs previous closeSession (open→close): −7.0%

Session: day range 28.00–30.39, VWAP 28.61 (below VWAP), IEX volume 2.75× its 20-day average. Trend: −49.6% over three months, 1% of the way up its 52-week range, RSI(14) 18, below its 50-day and below its 200-day average.

Intraday chart of IONS on 2026-11-10
Session (intraday)
Three-month daily chart of IONS
Three months (daily)
Revenue (latest FY)
$943.7M
Net income (latest FY)
−$381.4M
Cash
$296.3M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Ionis Pharmaceuticals Inc filings on SEC EDGAR

AESI

Atlas Energy Solutions Inc

5.36−3.2%
EnergyOil & Gas Equipment & Services
3 months−54.5%
52-week range52w low2%high
RSI (14)19
Session
above VWAP 5.280.70× avg vol
Moving averages
below 50dbelow 200d
View AESI chart on TradingView Affiliate
Case study: why AESI is on this page

Bottom of this screen: a net loss last fiscal year; revenue +3.7% YoY; below its 200-day average; near its 52-week low; -54.5% over 3 months.

Close 5.36: −3.2% vs previous closeSession (open→close): +2.9%

Session: day range 5.11–5.48, VWAP 5.28 (above VWAP), IEX volume 0.70× its 20-day average. Trend: −54.5% over three months, 2% of the way up its 52-week range, RSI(14) 19, below its 50-day and below its 200-day average.

Intraday chart of AESI on 2026-11-10
Session (intraday)
Three-month daily chart of AESI
Three months (daily)
Revenue (latest FY)
$1.10B
Net income (latest FY)
−$50.3M
Cash
n/a

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Atlas Energy Solutions Inc filings on SEC EDGAR

26matched the screen
26studied in depth
4on this page

Top of the screen

IDXX

Idexx Laboratories Inc

696.64−1.5%
HealthcareDiagnostics & Research
3 months+22.9%
52-week range52w low73%high
RSI (14)71
Session
at VWAP 693.910.62× avg vol
Moving averages
above 50dabove 200d
View IDXX chart on TradingView Affiliate
Case study: why IDXX is on this page

Top of this screen: profitable last fiscal year; revenue +10.4% YoY; above its 200-day average; +22.9% over 3 months.

Close 696.64: −1.5% vs previous closeSession (open→close): −0.2%

Session: day range 682.65–698.28, VWAP 693.91 (at VWAP), IEX volume 0.62× its 20-day average. Trend: +22.9% over three months, 73% of the way up its 52-week range, RSI(14) 71, above its 50-day and above its 200-day average.

Intraday chart of IDXX on 2026-11-10
Session (intraday)
Three-month daily chart of IDXX
Three months (daily)
Revenue (latest FY)
$4.30B
Net income (latest FY)
$1.06B
Cash
$197.5M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Idexx Laboratories Inc filings on SEC EDGAR

V

Visa Inc

423.00+0.1%
FinancialCredit Services
3 months+15.8%
52-week range52w low87%high
RSI (14)63
Session
at VWAP 422.710.96× avg vol
Moving averages
above 50dabove 200d
View V chart on TradingView Affiliate
Case study: why V is on this page

Top of this screen: profitable last fiscal year; revenue +14.8% YoY; above its 200-day average; +15.8% over 3 months.

Close 423.00: +0.1% vs previous closeSession (open→close): +0.5%

Session: day range 419.12–424.90, VWAP 422.71 (at VWAP), IEX volume 0.96× its 20-day average. Trend: +15.8% over three months, 87% of the way up its 52-week range, RSI(14) 63, above its 50-day and above its 200-day average.

Intraday chart of V on 2026-11-10
Session (intraday)
Three-month daily chart of V
Three months (daily)
Revenue (latest FY)
$45.90B
Net income (latest FY)
$23.50B
Cash
$12.94B

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Visa Inc filings on SEC EDGAR

Bottom of the screen

ALNY

Alnylam Pharmaceuticals Inc

151.61−3.1%
HealthcareBiotechnology
3 months−33.2%
52-week range52w low1%high
RSI (14)21
Session
below VWAP 152.581.07× avg vol
Moving averages
below 50dbelow 200d
View ALNY chart on TradingView Affiliate
Case study: why ALNY is on this page

Bottom of this screen: profitable last fiscal year; revenue +65.2% YoY; below its 200-day average; near its 52-week low; -33.2% over 3 months.

Close 151.61: −3.1% vs previous closeSession (open→close): −2.4%

Session: day range 149.21–158.82, VWAP 152.58 (below VWAP), IEX volume 1.07× its 20-day average. Trend: −33.2% over three months, 1% of the way up its 52-week range, RSI(14) 21, below its 50-day and below its 200-day average.

Intraday chart of ALNY on 2026-11-10
Session (intraday)
Three-month daily chart of ALNY
Three months (daily)
Revenue (latest FY)
$3.71B
Net income (latest FY)
$313.7M
Cash
$1.75B

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Alnylam Pharmaceuticals Inc filings on SEC EDGAR

NVDA

NVIDIA Corp

169.10−5.5%
TechnologySemiconductors
3 months−25.1%
52-week range52w low6%high
RSI (14)24
Session
at VWAP 169.043.12× avg vol
Moving averages
below 50dbelow 200d
View NVDA chart on TradingView Affiliate
Case study: why NVDA is on this page

Bottom of this screen: profitable last fiscal year; revenue +65.5% YoY; below its 200-day average; near its 52-week low; -25.1% over 3 months.

Close 169.10: −5.5% vs previous closeSession (open→close): −2.8%

Session: day range 165.89–174.66, VWAP 169.04 (at VWAP), IEX volume 3.12× its 20-day average. Trend: −25.1% over three months, 6% of the way up its 52-week range, RSI(14) 24, below its 50-day and below its 200-day average.

Intraday chart of NVDA on 2026-11-10
Session (intraday)
Three-month daily chart of NVDA
Three months (daily)
Revenue (latest FY)
$215.94B
Net income (latest FY)
$120.07B
Cash
$22.44B

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: NVIDIA Corp filings on SEC EDGAR

The charts use the candlestick, VWAP and moving-average reading taught in our free courses. To pull up any of these tickers yourself, TradingView’s free plan covers it. Affiliate link: we may earn a commission if you subscribe, at no extra cost to you.

Reminder: nothing on this page is investment advice. These names appear because of where they landed in the screen, not because of any view on where the price goes next. Past performance does not indicate future results. See the Disclaimer.